Fig 3.

Validation of the consensus signature in stage I and II pancreatic ductal carcinoma from the United States cohort. The consensus signature generated from the Scandinavian cohort was validated in the independent cohort in the United States by classifying (A) normal controls (NC) v patients with pancreatic ductal adenocarcinoma (PDAC) stage I and II, and (B) patients with PDAC stage I and II v patients with chronic pancreatitis (CP). The results are presented as representative receiver operating characteristic curves and their corresponding area under the curve (AUC) values.